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Background: Bronchial asthma is one of the most prevalent diseases in Arab children. Environmental pollution has
been suggested to be considered causative of asthma, nasal symptoms and bronchitis in both children and adult.
The objectives of this study were to evaluate the association between serum polycyclic aromatic hydrocarbons
(PAHs) levels, asthma and allergic outcomes among Saudi children aged up to 15 yrs. We hypothesized that
increased serum PAHs are associated with allergy, asthma, or respiratory symptoms.
Methods: A total of 195 Saudi children (98 asthma pediatric patients and 97 healthy controls) were randomly
selected from the Riyadh Cohort Study for inclusion. The diagnosis of Asthma was based on established pediatric
diagnosis and medications taken.
Results: Asthma related markers showed highly significant differences between children with and without asthma.
Thus IgE, resistin and IL-4 were significantly increased (p 0.004, 0.001 and 0.003, respectively) in children with
asthma compared with non-asthma control subjects. GMCSF, IFN-γ, IL-5, IL-8 and IL-10, on the other hand, were
significantly decreased in children with asthma (p 0.003, 0.03, 0.001, 0.004 and 0.03, respectively). Strong associations
between serum PAHs levels and biomarkers of childhood asthma were detected in Arabic children. Data confirmed
the role of naphthalene, 4H-cyclobenta[def]phenanthrene, 1,2-benzanthracene, chrysene and benzo(e)
acephenanthrylene in childhood asthma; levels of these PAHs were correlated with asthma related biomarkers
including IgE, resistin, GMCSF and IFN-γ as well as IL-4, IL-5, IL-8 and IL-10 cytokines.
Conclusions: This data highlight the pivotal role of specific PAHs in childhood asthma.
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Asthma is one of the most common chronic diseases, that
is characterized by variable airflow obstruction, inflamma-
tion of the airways, and bronchial hyper responsiveness. It
affects nearly 14 million people worldwide and more than
2 million Saudis [1,2]. Asthma is the most frequent
chronic illnesses in childhood [2-4]. It has an impact on
patients, their families, and the community as a whole in
terms of lost work and school days, poor quality of life
and death cases [5]. Several potential determinants being
responsible for development of atopy and asthma have
been proposed, including lack of severe and repeated* Correspondence: ndaghri@ksu.edu.sa
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reproduction in any medium, provided the orinfections [6,7], obesity and lack of physical exercise [8], a
small family size [9-11], changing dietary habits [12,13]
and increased indoor allergen exposure [14,15].
Polycyclic aromatic hydrocarbons (PAHs) are pro-
duced during the incomplete combustion of organic ma-
terial such as fuels, coal, wood, tobacco, and oil. Vehicle
emissions are major sources of PAHs in urban areas
[16,17]. Blood and urine PAHs levels are proposed as
specific biomarkers of PAHs exposure via inhalation of
polluted air and intake of certain foods (e.g. charcoal
broiled meats and other smoked foods) [18]. Exposure
to high levels of air pollutants has been associated with
decreased lung function, asthma, nasal symptoms, bron-
chitis and sensitization to inhalant allergens in both chil-
dren and adults [19-23]. These studies implicate traffic-
related emissions, largely composed of diesel exhaustral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gen dioxide, particulate matter, and PAHs in the develop-
ment of respiratory symptoms, asthma or the onset of
allergies. Studies have shown that exposure to PAHs be
associated with adverse respiratory health outcomes. Previ-
ous data reported that exposure to PAHs such as benz(a)
anthracene, benzo(a)pyrene, benzo(b)fluoranthene, benzo
(g,h,i)perylene, chrysene and dibenz(a,h)anthracene are
associated with increased cough and wheeze at age
12 months, and breathing problems as well as development
of asthma [24,25]. Notably, PAHs exposure was suggested
to favor proallergic immunoglobulin IgE responses. Re-
cently, the U.S. National Health and Nutrition Examination
Survey (NHANES) (1999–2000, 2001–02) provided com-
prehensive descriptions of reference ranges for a larger
panel of PAHs metabolites collected from a population of
children and adults without suspected occupational expo-
sures [20,22]. Higher levels were detected among children,
suggesting that they may be at greater risk for adverse
health effects. The objectives of this study were to evaluate
the association between serum PAHs level with asthma
among Saudi children up to 8 yrs. Our starting hypothesis
being that increased serum PAHs are associated with al-
lergy, asthma, or respiratory symptoms.
Methods
Study subjects
A total of 195 Saudis children aged 15 years old and
below, (98 asthma pediatric patients and 97 healthy con-
trols) were randomly selected from the Riyadh Cohort
Study for inclusion. The parent or guardian of each child
was asked to answer a questionnaire consisting of demo-
graphic information which included dietary questions,
area of residence (near the factory, high-traffic area,
etc.), presence of a smoker at home and other pertinent
questions related to asthma. Asthma was based on estab-
lished pediatric diagnosis and medications taken. Since
most of the subjects were asymptomatic during the
course of the study, parents were asked if the child had
history of wheezing upon exhalation, frequent episodes
of chest tightness and hyper-expansion of thorax with
use of accessory muscles. Ethical approval was granted by
the Ethics Committee of the College of Science Research
Center, King Saud University, Riyadh, KSA.
Anthropometrics
Anthropometry included height (rounded off to the near-
est 0.5 cm) and weight (rounded off to the nearest
0.1 kg), which were measured using an appropriate inter-
national standard scale (Digital Person Scale; ADAM
Equipment, Milford, CT, USA), as well as waist and hip
circumference in centimeters, which were measured using
a standard tape measure; and body mass index (BMI) was
calculated as kg/m2. The Holtain Khan abdominal caliperby Holtain Ltd (Crymych, UK) was used to measure sagi-
tal abdominal diameter (SAD).
Biochemical parameters
Fasting blood was collected by an assigned physician at
their respective primary healthcare centers. Blood was
drawn, centrifuged and processed on the same day. Both
whole blood and serum were placed in plain polystyrene
tubes. Serum was delivered to Biomarker Research Pro-
gram (BRP) for storage at −20°C. Fasting serum glucose
levels, and complete lipid profile (triglycerides, total chol-
esterol, high density lipoprotein [HDL]-cholesterol) were
determined using a biochemical analyzer (Konelab, Espoo,
Finland). Low density lipoprotein (LDL)-cholesterol was
calculated using Friedman formula. This biochemical
analyzer was calibrated routinely prior to the analysis of
all serum samples using quality control samples provided
by the manufacturer (Thermo-Fisher Scientific, Espoo,
Finland). LINCOplex, human multiplex immunoassay
kit based on Luminex 100 system platform (Luminex
Corporation, Austin, TX, USA) was used for determin-
ation of three different panels by simultaneous detection
of a great variety of cytokines, interleukins and immuno-
globulines. The standard protocol for the process was fol-
lowed. The concentrations of analyte in each sample were
calculated with a five parameter model using Luminex IS
software ver. 2.3.
PAH analysis
A stock solution of 12 PAHs mixed standard solutions
was prepared by dissolving 1 mg from each PAH in 100
ml acetonitrile. The series of PAHs mix standard (0.0,
0.5, 2.5, 5, 10, 50 and 100 ng ml-1) were prepared in
acetonitrile for linearity. Calibration curves were gener-
ated by plotting peak area versus concentration. Each
subject’s sample was analyzed for a suite of 12 PAHs as
previously described [23]. Analytical determination was
conducted by using liquid-liquid extraction followed by
high performance liquid chromatography with fluores-
cence detector (HPLC-FLD). Standard calibration curve
was presented excellent linearity, with good separation
and repeatability. The limit of detection (LOD) was
defined as the higher value of either the method blank
LOD (three times standard deviation of method blank
after subtracting the average blank), or the instrument
LOD (signal >3 times the signal to noise ratio). The limit
of quantification (LOQ) (signal >10 times the signal to
noise ratio). The limits of detection were ranged from
1.2 to 4.0 ng ml-1 (0.001 ppm). The lowest possible
standard on the calibration curve was accepted as the
LOQ. The calibration curve and recovery validation
study were all repeated three times (n = 3). Recovery
and precision were estimated by using spiked blank
matrix, samples were analysed in duplicate at five levels
Table 1 Characterization of asthmatic children compared
to non-asthma control subjects
Parameters Control Asthma P value
Age (years) 13.5 ± 4.2 13.7 ± 2.9 0.81
BMI (kg/m2) 21.1 ± 5.5 21.3 ± 6.6 0.81
Waist circumference (cm) 66.6 ± 15.1 70.7 ± 17.1 0.09
Hip circumference (cm) 82.1 ± 20.7 83.8 ± 19.9 0.54
SAD (cm) 17.0 ± 7.5 17.7 ± 19.6 0.53
Cholesterol (mmol/l) 4.3 ± 0.88 4.1 ± 0.72 0.07
Glucose (mmol/l) 5.3 ± 1.7 5.3 ± 1.7 0.90
HDL-Cholesterol (mmol/l) 1.04 ± 0.34 0.90 ± 0.31 0.008
Triglycerides (mmol/l) 1.1 ± 0.60 1.03 ± 0.41 0.59
LDL-Cholesterol (mmol/l) 2.8 ± 0.80 2.7 ± 0.67 0.21
IgE (pg/ml) 61.1 ± 4.3 123.1 ± 5.0 0.004
Resistin (pg/ml) 17.3 ± 1.3 24.5 ± 1.6 <0.001
GMCSF (pg/ml) 1.9 ± 0.10 1.0 ± 0.11 0.003
INF-gamma (pg/ml) 2.4 ± 0.74 1.6 ± 0.63 0.03
IL4 (pg/ml) 9.2 ± 1.4 18.5 ± 3.6 0.003
IL5 (pg/ml) 0.92 ± 0.20 0.52 ± 0.17 <0.001
IL8 (pg/ml) 12.4 ± 1.8 6.3 ± 1.2 0.004
IL10 (pg/ml) 12.1 ± 1.7 9.2 ± 1.4 0.03
Naphthalene (ng/ml) 10.7 ± 2.7 26.2 ± 2.5 <0.001
Anthracene (ng/ml) 239.5 ± 22.6 260.1 ± 52.3 0.79
Fluorene (ng/ml) 2.5 ± 0.75 3.6 ± 0.90 0.04
Phenanthrene (ng/ml) 9.3 ± 1.7 11.5 ± 1.9 0.13
4H-cyclobenta[def]phenanthrene
(ng/ml)
6.2 ± 1.1 20.3 ± 2.1 <0.001
Pyrene (ng/ml) 0.67 ± 0.34 1.1 ± 0.50 0.04
Flouranthene (ng/ml) 26.9 ± 3.2 31.8 ± 3.4 0.60
1,2-benzanthracene (ng/ml) 0.37 ± 0.24 0.73 ± 0.36 0.01
Chrysene (ng/ml) 0.87 ± 0.19 1.8 ± 0.13 0.001
Benzo(e)pyrene (ng/ml) 1.6 ± 0.17 2.6 ± 0.20 0.32
Benzoacephenanthrylene (ng/ml) 1.7 ± 0.23 7.0 ± 0.90 0.006
Benzo(a)pyrene (ng/ml) 2.1 ± 0.80 4.8 ± 0.93 0.02
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were calculated from the analytical signal as the ratio be-
tween found and expected expressed in %. The rate of
recovery for all 12 PAHs were ranged from 86 to 106%.
Statistical analysis
Data represented by mean ± standard deviation. Skewed
data was either log or square root transformed. Non
Gaussian variables were represented by median and inter
quartile ranges. Two samples independent T–test was per-
formed to compare control and asthma. Mann Whitney U
test was performed to compare control and asthmatic,
wherever variables don’t follow Gaussian distribution.
P values <0.05 were considered statistically significant.
Pearson’s correlation test was performed to examine vari-
ous correlations. Analyses were performed with the SPSS-
PC software, version 16.0 (SPSS Inc, Chicago, IL).
Results
Subjects characteristics
The epidemiological characterization of the 195 Saudis
children included in the study (98 asthma pediatric
patients and 97 non-asthma control subjects) is provided
in Table 1. All children were comparable regards to
BMI, waist, SAD, total cholesterol, glucose, triglycerides
and LDL-cholesterol.
Association between PAH and asthma markers
Not surprisingly, asthma related biochemical markers
showed highly significant differences between children
with asthma and non-asthma control subjects. Thus,
compared to non-asthma control subjects significant in-
crease in level of IgE (123.1 ± 5.0 vs. 61.1 ± 4.3, p =
0.004), resistin (24.5 ± 1.6 vs. 17.3 ± 1.3, p = 0.001) and
IL-4 (18.5 ± 3.6 vs. 9.2 ± 1.4, p = 0.003) pg ml-1. While
there was significant decrease in levels of GMCSF (1.0 ±
0.11 vs. 1.9 ± 0.1, p = 0.003), IFN-γ (1.6 ± 0.63 vs. 2.4 ±
0.74, p = 0.03), IL-5 (0.52 ± 0.17 vs. 0.92 ± 0.2, p =
0.001), IL-8 (6.3 ± 1.2 vs. 12.4 ± 1.8, p = 0.004) and IL-10
(9.2 ± 1.4 vs. 12.1 ± 1.7, p = 0.03) pg ml-1.
Quantification of PAHs showed the presence of sig-
nificant difference between children with asthma and
non-asthma control subjects in levels of naphthalene
(26.2 ± 2.5 vs. 10.7 ± 2.7, p 0.001), fluorene (3.6 ± 0.90
vs. 2.5 ± 0.75, p 0.04), 4H-cyclobenta[def]phenanthrene
(20.3 ± 2.1 vs. 6.2 ± 1.1, p = 0.001), pyrene (1.1 ± 0.50 vs.
0.67 ± 0.34, p = 0.04), 1,2-benzanthracene (0.73 ± 0.36
vs. 0.37 ± 0.24, p = 0.01), chrysene (1.8 ± 0.13 vs. 0.87 ±
0.19, p = 0.001), benzoacephenanthrylene (7.0 ± 0.90 vs.
1.7 ± 0.23, p = 0.006) and benzo(a)pyrene (4.8 ± 0.93 vs.
2.1 ± 0.80, p = 0.02) ng ml-1. In contrast with these
results, no differences were detected between the two
groups in the levels of anthracene, phenanthrene, fluor-
anthene and benzo(e)pyrene.To examine the role of PAHs in asthma, we analysed
the association between PAHs and markers of asthma
(Table 2). Our results clearly showed strong correlation
between serum PAHs levels and asthma related biomar-
kers in Arab children. Thus, serum naphthalene was posi-
tively associated with IgE (r = 0.18, p = 0.03), IL-4 (r =
0.54, p =0.001) and resistin (r = 0.19, p = 0.02) and nega-
tively associated with IL-5 (r = −0.18, p = 0.03). 4H-cyclo-
benta[def]phenanthrene was positively associated with IgE
(r = 0.18, p = 0.03), IL-4 (r = 0.54, p = 0.001) and nega-
tively associated with IL-10 (r = −0.23, p = 0.02). 1,2-
benzanthracene was positively associated with IgE (r =
0.27, p = 0.006), resistin (r = 0.34, p =0.001) and nega-
tively associated with IL-10 (r = −0.21, p = 0.03). Benzo
Table 2 Correlation between asthma related biomarkers and serum PAH Levels
Resistin IFN-γ IL-4 IL-5 IL-8 IL-10 IgE
Naphthalene 0.19* −0.05 0.54** 0.18* −0.08 −0.11 0.18*
Anthracene 0.02 −0.004 0.05 −0.04 −0.03 −0.07 0.05
Flourene −0.07 −0.08 −0.07 −0.14 −0.03 −0.003 −0.03
Phenantherene 0.11 −0.10 0.25** 0.06 0.09 −0.06 −0.14
4H-cyclobenta[def] phenanthrene 0.15 −0.18 0.78** −0.12 −0.17 −0.23* 0.20*
Pyrene 0.008 −0.07 −0.09 0.08 −0.21* 0.06 0.21*
Flouranthene 0.26** −0.19* 0.17 0.03 −0.07 0.10 −0.006
1,2-benzanthracene 0.34** 0.05 −0.14 0.002 −0.06 −0.21* 0.27**
Chrysene 0.03 0.001 0.08 0.31** −0.23* 0.06 0.16
Benzo(e)pyrene 0.13 0.007 0.32** −0.17 0.02 −0.17 −0.03
Benzo(e)acephenanthrylene 0.28** −0.10 0.45** 0.26** −0.01 −0.28** 0.08
Benzo(a)pyrene 0.37** 0.11 −0.17 0.07 0.01 −0.26** 0.06
(*): significant at P ≤ 0.05.
(**): significant at P ≤ 0.01.
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(r = 0.45, p = 0.001), resistin (r = 0.28, p = 0.004) and
negatively associated with IL-5 (r = −0.26, p = 0.009),
IL-10 (r = −0.28, p = 0.005). Benzo(a)pyrene was posi-
tively associated with resistin (r = 0.37, p = 0.001) and
negatively associated with IL-10 (r = −0.26, p = 0.009).Discussion
Our objectives were to analyze serum PAHs levels in
children with asthma, establishing possible correlations
between such levels and asthma-related biomarkers.
Data herein show that different levels of PAHs are
detected in asthmatic compared to non-asthma control
subjects. PAHs levels were significantly increased in
asthmatic individuals compared to non-asthma control
subjects. Differences were observed in PAHs levels, de-
pending on the individual PAH, but most commonly for
naphthalene, 4H-cyclobenta[def]phenanthrene, 1,2-ben-
zanthracene, chrysene, Benzo(e)acephenanthrylene. Previ-
ous studies considered naphthalene to be a more specific
indicator of exposure to airborne PAH exposure [26,27].
PAHs level detected are likely to reflect differences attrib-
utable to the ubiquitous traffic-related and other sources
of air pollution in the urban environment of the studied
cohort. These findings also could reflect differences in
dietary intake [28]. Regardless, they may be indicators of
greater potential risk for the later development of PAH-
associated diseases.
Mechanisms underlying the differences in PAHs levels
may be multifactorial. These may be impacted by dietary
preferences or lifestyle behaviors not measured in this
study which might explain such changes. Additionally,
genetic factors may impact on the metabolism of thesecompounds. Some of these possibilities have also been
suggested by the NHANES report [20].
The present study showed positive associations be-
tween IgE and PAHs (naphthalene, 4H-cyclobenta[def]
phenanthrene, 1,2-benzanthracene). The associations be-
tween PAHs levels and IgE levels reported in other studies
indeed suggest that exposure to traffic-related air pollu-
tion results in an up-regulation of allergic immune
responses [29-31]. In vitro studies have demonstrated that
PAH-enhance IgE production via their effects on tensile B
cells [32]. Exposure to pyrene has been associated with
up-regulation of the IL-4 promoter [33]. In addition, dif-
ferent PAHs pyrene, benzo(a)-pyrene, anthracene, phen-
anthrene and fluoranthene has been shown to induce IgE
production, T helper 2 cytokine productions in both ro-
dent and studies highlighting the cellular impact of PAHs
on metabolism and the immune response [34-36].Conclusion
Our results show that serum PAHs level is correlated with
multiple asthma related biomarkers in children. Results
herein also support the importance of Naphthalene, 4H-
cyclobenta[def]phenanthrene, 1,2-benzanthracene, Chry-
sene and Benzo(e)acephenanthrylene in childhood asthma
and clearly indicate that the plasma concentration of
these compounds correlate with asthma related biomar-
kers including IgE, resistin, GMCSF, IFN-γ, IL-4, IL-5, IL-8
and IL-10.Abbreviations
PAHs: Polycyclic aromatic hydrocarbons; BMI: Body mass index; LDL: Low
density lipoprotein; HDL: High density lipoprotein; SAD: Sagittal abdominal
diameter.
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